Evaluation of PD-L1 and TIM-3 Pathways in T Cells During Experimental Bovine Leukemia Virus Infection in Sheep
2025
Wisa Tiyamanee | Tomohiro Okagawa | Shinji Yamada | Mari Ikehata | Hayato Nakamura | Maho Inoue | Naoya Maekawa | Yukinari Kato | Shiro Murata | Kazuhiko Ohashi | Kenji Murakami | Satoru Konnai
Bovine leukemia virus (BLV) infects B cells in ruminants and causes lymphoma after an extended latency period. Previous studies have demonstrated T-cell exhaustion through the upregulation of immunoinhibitory molecules, including programmed death-ligand 1 (PD-L1) and T-cell immunoglobulin and mucin domain-3 (TIM-3), in BLV-infected cattle. However, studying T-cell exhaustion across all BLV infection stages remains challenging due to the virus&rsquo:s prolonged latency in cattle. Sheep provide a valuable model, as they develop lymphoma more rapidly than cattle. This study examined PD-L1 and TIM-3 expression kinetics and T-cell function in BLV-infected sheep. During persistent infection, PD-L1 expression was correlated with BLV proviral load. TIM-3 expression increased in CD4+, CD8+, and &gamma:&delta:TCR+ T cells. Functional analysis revealed that TIM-3 blockade enhanced T-cell activation markers (CD25 and CD69) in cultured PBMCs from infected sheep and increased CD69+IFN-&gamma:+ and CD69+TNF-&alpha:+ populations, particularly among CD4+ T cells. Combined PD-L1 and TIM-3 blockade significantly enhanced cytokine production in both CD4+ and CD8+ T cells, while PD-L1 blockade alone showed limited effects. These findings demonstrate the effect of TIM-3 blockade in restoring immune function during chronic BLV infection, effective both alone and in combination. This study validates sheep as a valuable model for investigating immune checkpoint dynamics and evaluating immunotherapies for BLV infection and other chronic diseases.
显示更多 [+] 显示较少 [-]